| 词条 | Mesoridazine |
| 释义 |
| Watchedfields = changed | verifiedrevid = 462249027 | IUPAC_name = 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine | image = Mesoridazine.svg | tradename = Serentil | Drugs.com = {{drugs.com|CONS|mesoridazine}} | MedlinePlus = a682306 | pregnancy_US = C | legal_status = Rx-only | routes_of_administration = Oral, intravenous | bioavailability = | protein_bound = 4% | metabolism = Hepatic/renal | elimination_half-life = 24 to 48 hours | excretion = Biliary and renal | IUPHAR_ligand = 7227 | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 5588-33-0 | ATC_prefix = N05 | ATC_suffix = AC03 | ATC_supplemental = | PubChem = 4078 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00933 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 3936 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 5XE4NWM740 | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D02671 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 6780 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 1088 | C=21 | H=26 | N=2 | O=1 | S=2 | molecular_weight = 386.576 g/mol | smiles = O=S(c2cc1N(c3c(Sc1cc2)cccc3)CCC4N(C)CCCC4)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C21H26N2OS2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = SLVMESMUVMCQIY-UHFFFAOYSA-N | melting_point = 130 | solubility = insoluble }} Mesoridazine (Serentil) is a piperidine neuroleptic drug belonging to the class of drugs called phenothiazines, used in the treatment of schizophrenia. It is a metabolite of thioridazine. The drug's name is derived from the methylsulfoxy and piperidine functional groups in its chemical structure. It has central antiadrenergic, antidopaminergic, antiserotonergic and weak muscarinic anticholinergic effects. Serious side effects include akathisia, tardive dyskinesia and the potentially fatal neuroleptic malignant syndrome. Mesoridazine was withdrawn from the United States market in 2004 due to dangerous side effects, namely irregular heart beat and QT-prolongation of the electrocardiogram.[1] It currently appears to be unavailable worldwide. References1. ^[https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682306.html] {{Antipsychotics}}{{Navboxes| title = Pharmacodynamics | titlestyle = background:#ccccff | list1 ={{Adrenergic receptor modulators}}{{Dopamine receptor modulators}}{{Histamine receptor modulators}}{{Muscarinic acetylcholine receptor modulators}}{{Serotonin receptor modulators}} }}{{Tricyclics}}{{nervous-system-drug-stub}} 5 : Muscarinic antagonists|Phenothiazines|Piperidines|Sulfoxides|Typical antipsychotics |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。